Leptin concentrations in women in the San Antonio heart study: Effect of menopausal status and postmenopausal hormone replacement therapy

American Journal of Epidemiology

Volumn 146, Issue 7, 1997, Pages 581-585

  Haffner, Steven M ^a   Mykkänen, Leena ^a   Stern, Michael P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Hormones; Menopause; Obesity; Sex; Sex hormones

Indexed keywords

LEPTIN;

ADULT; ARTICLE; BODY MASS; CEREBROSPINAL FLUID ANALYSIS; ESTROGEN BLOOD LEVEL; FEMALE; GENE EXPRESSION; HORMONE SUBSTITUTION; HUMAN; HYPOTHESIS; MENOPAUSE; OBESITY; PREMENOPAUSE; PROTEIN ANALYSIS; RISK FACTOR; SEX DIFFERENCE;

EID: 2642676081     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009317     Document Type: Article

References (27)

1. Masuzaki H, Ogawa Y, Isse N, et al. Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 1995;44:855-8.
2. Lönnqvist F, Arner P, Nordfors L, et al. Overexpression of the obese (OB) gene in adipose tissue of human obese subjects. Nature Med 1995;1:950-3.
3. Hamilton BS, Paglia D, Kwan AYM, et al. Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med 1995;1:953-6.
4. Considine RV, Considine EL, Williams CJ, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995;95:2986-8.
5. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and OB RNA in obese and weight-reduced subjects. Nature Med 1995;1: 1155-61.
6. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 1996;334:292-5.
7. Ma ZA, Gingerich RL, Santiago JV, et al. Analyses of human plasma leptin by radioimmunoassay. Clin Chem 1996;42: 942-6.
8. Haffner SM, Gingerich RL, Miettinen H, et al. Leptin concentrations in relation to overall adiposity and regional body fat distribution in San Antonio. Int J Obes 1996;20:904-8.
9. Saad MF, Damani S, Gingerich RL, et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinal Metab 1997; 82:579-84.
10. Ostlund RE Jr, Klein S, Yang JW. Relation between plasma leptin concentration, body composition and metabolic covariates. Diabetes 1996;45(suppl 2):41A.
11. Frederich RC, Hamann A, Anderson S, et al. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nature Med 1995;1:1311-14.
12. Schwartz MW, Peskind E, Raskind M, et al. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Med 1996;2:589-93.
13. Stern MP, Rosenthal M, Haffner SM, et al. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol 1984;120:834-51.
14. Haffner SM, Stern MP, Hazuda HP, et al. Hyperinsulinemia in a population at high risk for non-insulin dependent diabetes mellitus. N Engl J Med 1986;315:220-4.
15. Hazuda HP, Comeaux PJ, Stern MP, et al. A comparison of three indicators for identifying Mexican Americans in epidemiologic research: methodological findings from the San Antonio Heart Study. Am J Epidemiol 1986;123:96-112.
16. Haffner SM, Hazuda HP, Mitchell BD, et al. Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 1991;14:102-8.
17. Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican Americans. Diabetes 1995;44:1386-91.
18. World Health Organization Study Group on Diabetes Mellitus. Diabetes mellitus: report of a WHO study group. Geneva: WHO, 1985:94-8. (Technical report no.727).
19. Haffner SM, Stern MP, Miettinen H, et al. Leptin concentrations in diabetic and non-diabetic Mexican Americans. Diabetes 1996;45:822-4.
20. Wei M, Haffner SM, Stern MP. Serum leptin levels in Mexican Americans and non-Hispanic whites: association with BMI and cigarette smoking. Ann Epidemiol 1997;7:81-6.
21. Hassink SG, Sheslow DV, de Lancey E, et al. Serum leptin in children with obesity: relationship to gender and development. Pediatrics 1997;98:201-3.
22. Rosenbaum M, Nicolson M. Hirsch J, et al. Effects of gender, body composition, and menopause in plasma concentrations of leptin. J Clin Endocrinal Metab 1996;9:3424-7.
23. Haffner SM, Stern MP, Hazuda HP, et al. Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. Int J Obesity 1986;10:493-502.
24. Pouliot M, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-8.
25. Stephens TW, Baslnski M, Bristown PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-2.
26. Billington CJ, Briggs JE, Grace M, et al. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 1991;260:R321-7.
27. Urban JH, Bauer-Dantoin AC, Levine JE. Neuropeptide Y gene expression in the arcuate nucleus: sexual dimorphism and modulation by testosterone. Endocrinology 1993;132: 139-45.